Curriculum vitae matthew ryan weir, M. D



Download 0.51 Mb.
Page7/7
Date conversion04.02.2017
Size0.51 Mb.
1   2   3   4   5   6   7
Weir MR Presentation at the 5th Annual Meeting of the American Society of Hypertension. "Favorable effects of nicardipine on the quality of life during hypertension treatment," May 1990.

  • Invited Speaker: Medical Grand Rounds, University of Arkansas Medical Center, Little Rock, AR. "Antihypertensive therapy and the kidney: Is renal protection possible," May 1990.

  • Invited Speaker: Medical Grand Rounds, Henry Ford Hospital, Detroit, MI. "Prostaglandins and the kidney," May 1990.

  • Invited Speaker, plenary program, American Society of Transplant Physicians Annual Meeting, Chicago, IL. "The use of calcium antagonists in Organ Transplantation," May 1990.

  • Weir MR Presentation at the 9th Annual Meeting of the American Society of Transplant Physicians. "Verapamil has immunosuppressive properties unrelated to its ability to block slow calcium channel," June 1990.

  • Weir MR Presentation at the 9th Annual Meeting of the American Society of Transplant Physicians. "Immunosuppressive properties of enisoprost and SC45662 (5-Lipoxygenase Inhibitor)," June 1990.

  • Medical Grand Rounds, Philadelphia Naval Hospital, Philadelphia, PA. "Prostaglandins and the kidney," July 1990.

  • Medical Grand Rounds, St. Joseph's Hospital, Atlanta, GA. "Prostaglandins and the kidney, August, 1990.

  • Invited Speaker: Medical Grand Rounds, York Hospital, PA. "Prostaglandins and the kidney," August, 1990.

  • Invited Speaker, Plenary Session, 9th Annual Meeting of the American Society of Transplant Physicians, San Francisco. "Immunosuppressive properties of enisoprost and SC45662 (5-Lipoxygenase Inhibitor)," August, 1990

  • Invited Speaker: Transplantation Grand Rounds/Research Conference University of Wisconsin Medical Center, Madison, WI. "Newer immunosuppressive agents." August, 1990.

  • Invited Speaker: Medical Symposium, Delaware County Medical Society, Philadelphia, PA. "Antihypertensive therapy and the kidney," October, 1990.

  • Invited Speaker: Research Conference, East Carolina University Medical Center, Greenville, N.C. "Newer immunosuppressive agents," October, 1990.

  • Invited Speaker: Medical Grand Rounds, St. John's Hospital, Detroit, MI. "A physiologic approach to blood pressure control," October, 1990.

  • Invited Speaker: Medical Grand Rounds, Harford Memorial Hospital, Havre de Grace, MD. "Antihypertensive agents and the kidney," October, 1990.

  • Invited Speaker: American College of Clinical Pharmacy Symposium, Atlanta, GA. "A physiologic approach to blood pressure control," November, 1990.

  • Invited Speaker, Medical Grand Rounds & Teaching Sessions, The Reading Hospital, Reading, PA. "Prostaglandins and the kidney," November, 1990.

  • Medical Grand Rounds, Vassar Brothers Hospital, Poughkeepsie, N.Y. "The physiology of blood pressure control," December, 1990.

  • Invited Speaker, American Society of Nephrology Satellite Symposium, Washington, D.C. "Hypertensive renal injury in blacks: Implications for therapy," December, 1990.

  • Weir MR. Presentation at the American Society of Nephrology Symposium, Washington, D.C. "The antiproliferative effect of verapamil on human peripheral blood lymphocytes is independent of calcium channel inhibitors, December, 1990.

  • Weir MR. Presentation at the American Society of Nephrology Symposium, Washington, D.C. "Suppression of urinary thromboxane does not improve renal function in cyclosporine-treated renal transplant recipients," December, 1990.

  • Invited Speaker, Research Conference and Visiting Professor, Miami VAH, Miami, FL. "Prostaglandins and the kidney, December, 1990.

  • Invited Speaker: Medical Grand Rounds, Univ of Illinois, Chicago, IL. "The physiology of blood pressure control: implications for target organ protection," May, 1991.

  • Invited Speaker: America Heart Assoc Forum. Chicago, IL. "The genesis of cyclosporine-mediated hypertension." May, 1991.

  • Weir MR. Presentation at the 10th Annual Meeting of the American Society of Transplant Physicians, Chicago, IL. "The antiproliferative effect of verapamil on human peripheral blood mononuclear cells in independent of calcium channel inhibition." May, 1991.

  • Moderator & Presenter, Postgraduate Course of the American Society of Transplant Surgeons, Chicago, IL. "The emerging role of calcium antagonists in Organ Transplantation," May, 1991.

  • Invited Speaker: Medical Grand Rounds, Harper Hospital-Wayne State Univ., Detroit, MI. The immunosuppressive effects of calcium antagonists in organ transplantation," January, 1991.

  • Invited Speaker: UCSD Course: Advanced nephrology for the consultant. "Newer aspects of inductive immunotherapy "and" cyclosporine and the kidney," February, 1991.

  • Invited Speaker: Florida Academy of Family Physicians Orlando, FL. "Renal considerations with antihypertensive therapy," February, 1991.

  • Invited Speaker: American College of Cardiology Satellite Symposium, Kona HI. "Physiologic approach to blood pressure control: Implications for target organ protection," February, 1991.

  • Invited Speaker: Medical Grand Rounds, Portsmouth Naval Hospital, Portsmouth, VA. "Hypertension and the Kidney," February, 1991

  • Invited Speaker: Medical Grand Rounds: The Hoag Hospital, Newport Beach, CA. "The physiology of blood pressure control: implications for target organ protection," March, 1991.

  • Invited Speaker: UCSD symposium on "Recent advances in geriatric medicine." Presentation on: "Diabetic hypertension: a special problem," March, 1991.

  • Invited Speaker: Medical Grand Rounds, Division of Family Medicine, EVMS, Norfolk, VA. "Demographic issues in blood pressure management," March, 1991.

  • Invited Speaker: Medical Grand Rounds, Andrews AFB Hospital." Secondary causes of hypertension: Focus on the kidney," March, 1991.

  • Invited Speaker: Jefferson Medical College Symposium on Diabetes, Philadelphia, PA. "Hypertension and Diabetes: Physiologic Approaches," March, 1991.

  • Invited Speaker/Visiting Professor: Southern Illinois School of Medicine, Springfield, IL. Medical Grand Rounds, "The physiology of blood pressure control: Implications for target organ protection," April, 1991.

  • Invited Speaker: AHA Symposium on "Cardiovascular Diseases: Drug therapy," Baltimore, MD presentations on: "The Blockers" and "Therapeutic approaches to blood pressure control in minorities," May, 1991.

  • Invited Speaker: American Society of Gerontology, Chicago, IL. "Hypertension and the kidney," May, 1991.

  • Invited Speaker: Renal Grand Rounds at Francis Scott Key Medical Center, Baltimore, MD. "Calcium Antagonists in Organ Transplantation," May, 1991.

  • Invited Speaker: Transplant Grand Rounds at Washington Hospital Center, Washington, D.C. "In vitro methods for monitoring immunosuppression in organ transplant recipients," May 1991.

  • Invited Speaker: AHA Forum, Univ. of Chicago, Chicago IL. "Cyclosporine and the kidney," May 1991.

  • Weir MR: Presentation at the American Society of Transplant Physicians, Chicago, IL. "The antiproliferative effect of verapamil on human peripheral blood mononuclear cells is independent of calcium channel inhibition." May 1991.

  • Chairman of Symposium. 1991 American Society of Transplant Surgeons, Chicago, IL. "The clinical use of calcium antagonists in renal transplant recipients." May, 1991.

  • Invited Speaker: Medical Grand Rounds, Moses-Cone Community Hospital, Greensboro, NC. "Diabetes and Hypertension: Accelerated risk for renal injury." July, 1991.

  • Invited Speaker: NC Academy of Family Practice, Atlantic Beach, NC. "Acute Renal Failure." July, 1991.

  • Invited Speaker: Medical Grand Rounds, Medical Center of Delaware, Christiana, DE. "The physiology of blood pressure control: Implications for target organ protection." July 1991.

  • Invited Speaker: National Medical Association Meeting, Indianapolis, IN. "Hypertension and Renal Injury in Blacks," and "Update on Clinical Immunosuppression in Organ Transplantation." July 1991.

  • Invited Speaker: Illinois Academy of Family Practice, Chicago, IL. "Update in Organ Transplantation," August, 1991.

  • Invited Speaker: Medical Grand Rounds, Union Memorial Hospital, Baltimore, MD. "The Physiology of Blood Pressure Control: Implications for Target Organ Protection." August, 1991.

  • Invited Speaker: Medical Grand Rounds, Home Medical Center, Erie, PA. "The Physiology of Blood Pressure Control: Implications for Target Organ Protection." August, 1991.

  • Invited Speaker: Univ of Connecticut Nephrology Grand Rounds, St Francis Hospital, Hartford, CT. "Hypertensive Nephropathy: Is it preventable?" September, 1991.

  • Invited Speaker: Research Conference. Baystate Medical Center, Springfield, MA. "Newer approaches for inductive immunosuppression." September, 1991.

  • Invited Speaker: Medical Grand Rounds, Harlem Hospital Center, New York, NY. "Hypertension and Kidney Disease in Blacks," October, 1991.

  • Invited Speaker: Medical Grand Rounds, St. Agnes Hospital, Baltimore, MD. "The physiology of blood pressure control: Implications for Target Organ Protection." October, 1991.

  • Invited Speaker: Medical Grand Rounds, E. Orange VA Medical Center, Orange, NJ. "The physiology of blood pressure control: Implications for Target Organ Protection." October, 1991.

  • Weir MR. Presentation at the NIDDK Conference: Kidney Disease and Hypertension in Blacks. "Renal hemodynamic and antihypertensive effects on isradipine of salt-insensitive hypertensive patients on high and low sodium diets." November, 1991.

  • Invited Speaker: Medical Grand Rounds, East Carolina Univ, Greenville, NC. "The physiology of blood pressure control: Implications for target organ protection." December 1991.

  • Invited Speaker: Medical Grand Rounds, Oak Knoll Navel Hospital, Oakland CA. "The physiology of blood pressure control: Implications for renal protection." January, 1992.

  • Invited Speaker: Medical Grand Rounds, Livermore VAH, Livermore, CA. "The physiology of blood pressure control: Implications for renal protection." January 1992.

  • Invited Speaker: Medical Grand Rounds, Liberty Medical Center, Baltimore MD. "Diabetes and Hypertension: Accelerated risk for renal injury." January, 1992.

  • Invited Speaker: Medical Grand Rounds, Harford Memorial Hospital, Havre de Grace, MD. "The physiology of blood pressure control: Implications for target organ protection. February, 1992.

  • Invited Speaker: Medical Grand Rounds, Martin Luther King Hospital, Los Angeles, CA. "Race, Diabetes, and Hypertension. "Accelerated risk for renal injury." February, 1992.

  • Invited Speaker: Rheumatology Research Conference, Northwestern University Hospital, Chicago, IL "Non-steroidal Renal Syndromes." March, 1992.

  • Invited Speaker: Florida Academy of Family Practice Annual Meeting,

  • Perdicho Beach, FL. "Non-steroidal renal syndromes. " March, 1992.

  • Invited Speaker: Medical Grand Rounds, Sacred Heart Hospital, Spokane, WA. "The physiology of blood pressure control: Implications for target organ protection." March, 1992.

  • Invited Speaker: Nephrology Conference, Thomas Jefferson University Hospital, Philadelphia, PA. "The physiology of blood pressure control: implications for renal protection." March, 1992.

  • Invited Speaker: Research Conference, University of South Florida, Tampa, FL. "Ion flux and lymphocyte activation." April, 1992.

  • Weir MR. Presentation at the 5th Annual Meeting of American Society of Hypertension, New York, NY. "Effects of salt and isradipine on platelet Ca++ in salt sensitive and insensitive hypertensive patients." May, 1992.

  • Invited Speaker: Satellite Symposium of the 5th Annual Meeting of the American Society of Hypertension, New York, NY. "Is reducing proteinuria an important goal in the hypertensive diabetic?" May, 1992.

  • Invited Speaker: Medical Grand Rounds, University of New Mexico, Albuquerque, NM. "The physiology of blood pressure control: Implications for target organ protection." May 1992.

  • Invited Speaker: Nephrology Research Conference, University of Virginia, Charlottesville, VA. "Diabetes and Hypertension: Accelerated risk for renal injury." May 1992.

  • Weir MR. Presentation at the 11th Annual Meeting of the American Society of Transplant Physicians, Chicago, IL. "Mechanisms responsible for inhibition of lymphocyte activation by agents which block membrane calcium on potassium channels." May, 1992.

  • Invited Speaker: Canadian Consensus Conference on Renal/Endocrine Medical Problems, "Diabetes and Hypertension: Accelerated risk for Renal Injury." Calgary, Alberta. May, 1992.

  • Invited Speaker: Medical Grand Rounds, York Hospital, York, PA. "Non-steroidal renal syndromes." June 1992.

  • Invited Speaker: Satellite Symposium at National Medical Association Meeting, San Francisco, CA. "Influence of Race on the risk for hypertensive renal injury." August 1992.

  • Weir MR. Mechanisms responsible for inhibition of lymphocyte activation by agents which block membrane calcium or potassium channels. Presentation at International Congress of the Transplantation Society, Paris, France. August, 1992.

  • Invited Speaker: Medical Grand Rounds, Frederick Memorial Hospital, Frederick, MD "Hypertension and Diabetes: Accelerated risk for renal injury." August, 1992.

  • Invited Speaker: Geriatrics Research Conference and Department of Internal Medicine Symposium on "Health Issues in the Elderly," University of Iowa Hospital and Clinics, Iowa City, IA. "Influence of Aging and Hypertension on Renal Function in the elderly." September, 1992.

  • Invited Speaker: Kansas University Nephrology Society: "Update in Newer Therapeutic Modalities in Organ Transplantation." October. 1992.

  • Invited Speaker: American Dietetic Association National Meeting, Washington, DC. Influence of Non-pharmacologic/Pharmacologic interventions of the rate of progression of renal disease. October, 1992.

  • Invited Speaker: Medical Grand Rounds, Southern Maryland Medical Center, Clinton, MD. "The physiology of blood pressure control: Implications for target organ protection." November, 1992.Invited Session Chairman/Speaker at the National Kidney Foundation Annual Meeting, Baltimore, MD. Session: Special Considerations in Antihypertensive Therapy. "Hypertensive Nephropathy: Will a more physiologic approach to blood pressure control reduce the risk for renal injury?" November, 1992.

  • Invited Speaker: Grand Rounds, Beth Israel Medical Center, New York, NY. "Hypertensive Renal Injury: Can it be prevented?" January 1993.

  • Panelist, Lifetime Medical Television. "A review of JNC V." January, 1993.

  • Invited Speaker: Research Conference, University of Massachusetts, Worcester, MA." Calcium antagonists in organ transplantation." January 1993.

  • Invited Speaker: Research Conference, Wayne State University School of Medicine. "Importance of ion flux on lymphocyte activation." March 1993.

  • Invited Speaker: Grand Rounds, Roosevelt Hospital, New York, NY. "The physiology of blood pressure control." March, 1993.

  • Invited guest speaker on Television: "Health Today" for Howard County Community College. "Life style adjustments important for blood pressure control." April, 1993.

  • Invited Speaker: Grand Rounds, Methodist Hospital, Indianapolis, IN. "Prevention of target injury." April, 1993.

  • Visiting Professor, University of Texas Medical School, Houston, TX. "Research Conference: "Importance of ion flux on lymphocyte activation." May, 1993.

  • Visiting Professor, Baylor University College of Medicine, Houston, TX. Grand Rounds: "Hypertensive renal injury, can it be prevented?" May, 1993.

  • Invited Speaker: Grand Rounds, Washington VA Medical Center, Washington, D.C.: "Physiology of blood pressure control," June 1993.

  • Weir MR, Gomolka D, Handwerger BS. "Inhibition of lymphocyte activation by drugs that block calcium and potassium channels. Further insight into mechanisms of action." American Society of Transplant Physicians Abstract Book 1993; 12:311. Presented May, 1993

  • Keay S, Baldwin B, Weir MR. "Inhibition of CMV replication in vitro by the immunosuppressive agents Cyclosporine A, FK-506, and RS-61443." American Society of Transplant Physicians Abstract Book 1993;12:238. Presented May, 1993.

  • Invited Speaker: Renal Grand Rounds, Robert Wood Johnson Medical School, New Brunswick, NJ. "Update on Organ Transplantation," September 1993.

  • Invited Speaker: Renal Grand Rounds, Bowman-Gray School of Medicine, Winston Salem, NC. Progression of Renal Disease," October 1993.

  • Invited Speaker: Renal Grand Rounds, Duke University Medical Center, Durham, N.C. "Calcium Antagonists in Organ Transplantation," October 1993.

  • Invited Speaker: Renal Grand Rounds, Medical College of Virginia, Richmond, VA. "Calcium Antagonists in Organ Transplantation," November 1993.

  • Invited Speaker: Satellite symposium at the American Heart Association, Atlanta, GA. "Calcium-independent Antiproliferative effects of Calcium Antagonists," November 1993.

  • Invited Speaker: Research Conference at University of Alabama, Birmingham AL. "Calcium-independent antiproliferative effects of calcium antagonists," November 1993.

  • Invited Speaker: Plenary Session at National Kidney Foundation Annual Meeting, Boston, MA. "Hypertensive Nephropathy in African-Americans," November 1993.

  • Invited Speaker: Plenary Session at American Society of Nephrology Annual Meeting, Boston, MA.

    "Delayed Allograft Function," November 1993.

    1. Invited Speaker: American Society of Nephrology Clinical Program. "Hypertensive Nephropathy," November 1993.

    2. Weir MR, Houston MC, Grey JM. Effects of NSAIDS on blood pressure controlled by verapamil. 26th Annual Meeting of the American Society of Nephrology, Boston MA.

    3. Visiting Professor: Hahnemann University, Philadelphia, PA. "Renal protection: Where do ACE inhibitors and calcium channel blockers fit in?" January 1994.

    4. Visiting Professor: University of South Carolina, Columbia, SC. "Influence of dietary sodium and insulin resistance on the risk for hypertensive renal injury." April 1994.

    5. Renal Grand Rounds: George Washington University Hospital, Washington, D.C. "Influence of dietary sodium and insulin resistance on the risk for hypertensive renal injury." May 1994.

    6. Weir MR, Hall PS, Behrens MT. Greater Antihypertensive response to the calcium antagonist isradipine in salt-sensitive vs. salt-resistant hypertensives. Am Soc Hypertens (Presented May 1994)

    7. Weir MR, Behrens MT. Sodium sensitivity, independent of race, predicts higher filtration fraction and microalbuminuria in hypertensives on higher sodium intake. Am Soc Hypertens (Presented May 1994)

    8. Weir MR. A pilot study to assess the influence of isradipine therapy on proteinuria in hypertensive patients with Type II diabetes. Am Soc Hypertens (Presented May 1994)

    9. Invited Speaker: Symposium at American Society of Hypertension Annual Meeting. "Newer approaches for antihypertensive therapy." New York, NY, May 1994.

    10. Invited Speaker: Association of Black Cardiologists Meeting. "Effects of angiotensin II on hypertensive vascular injury." Orlando, FL, July 1994.

    11. Invited Speaker: National Medical Association Annual Meeting. "Influence of dietary sodium and insulin resistance on the risk for hypertensive renal injury in African-Americans." Orlando, FL, July 1994.

    12. Invited Speaker: Southeastern Dialysis and Transplantation Association Annual Meeting. "Salutory influences of calcium channel blockers in the cyclosporine-treated organ transplant recipients." Memphis, TN, August 1994.

    13. Invited Speaker: Nephrology Grand Rounds at the University of Miami Medical Center. "Influence of dietary salt and insulin resistance on the risk for hypertension and injury. February, 1995.

    14. Invited Speaker: Nephrology Grand Rounds at State University of New York.

    15. Invited Speaker: "Influence of dietary salt and insulin resistance on the risk for hypertension and injury." Syracuse, NY, April 1995.

    16. Walker JA, Klassen DK, Hoehn-Saric EW, Hooper FJ, Schweitzer EJ, Johnson LB, Bartlett ST, Weir MR. Acute Pancreas allograft rejection after the first year: Predisposing factors". Am Soc Transplant Physicians. (Presented May 1995).

    17. Weir MR, Saunders E, and the Tandolapril Multicenter Study Group. Differing mechanisms of action of angiotensin converting enzyme inhibition in black and white hypertensives. American Society of Hypertension (Presented May 1995).

    18. Weir MR, Prisant LM, Papadimitriou, Weber MA, Adegbile IA, Alemayehu D, Lefkowitz MP. Correlation of prior antihypertensive therapy current therapy (amlodipine, bisoprolol/HCTZ, enalapril), adverse events and blood pressure reduction with changes in quality of life. American Society of Hypertension (Presented May 1995).

    19. Weir MR, Dengel DR, Behrens MT, Goldberg AP. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. (Presented May 1995).

    20. Invited speaker: Southern Medical Association on "Influence of dietary salt and insulin resistance on the risk for hypotensive renal injury. Orlando, FL, November 1995.

    21. Medical Grand Rounds. Diabetic Nephropathy, North Shore Hospital

    22. National Kidney Foundation Symposium at Annual Meeting. “Hypertension in African Americans” 1996

    23. Grand Rounds. “Medical Complication in Renal Transplant Recipients” Howard University Hospital., 1996.

    24. University of Michigan Visiting Professor - Research Conference, Medical Grand Rounds. “Hypertension in African Americans”, 1996

    25. Visiting Professor, Bowman-Gray School of Medicine. Research Conference, Medical Grand Rounds. “Implications of Salt Sensitivity and Cardiovascular Risk, 1996

    26. National Kidney Foundation Annual Meeting: Symposium Chairman/Speaker. “Hypertension and the Kidney”., 1996

    27. University Program: South African Cardiology Society. Capetown, Johannesburg, Multiple lectures on Hypertensive Renal Injury in all major teaching hospitals. 1997

    28. Turkish Nephrology and Hypertension Society. Instanbul, Turkey - “Angiotensin Receptor Blockers and the Kidney”. 1997

    29. Duke University Medical Center. Medical Grand Rounds/Research Conference. Hypertension, Salt Sensitivity and Renal Injury.” 1997

    30. Plenary Speaker International Congress in ACE inhibition, Hong Kong. Is it the drug or blood pressure reduction which results in renal protection?” (Presented 1997).

    31. Society of Hypertension Plenary Program - Annual Meeting: Therapeutic approaches for patients with renal disease. New York. 1997

    32. Albert Einstein College of Medicine Research Conference: Salt Sensitivity and Renal Injury, 1997.

    33. Sattelite Symposium of American Society of Nephrology Meeting in San Antonio, Chairman/Speaker. How low should yo go and with which drugs?” 1997

    34. University of Virginia Transplant Research Conference “New treatments for chronic allograft nephropathy.” 1998

    35. University of Minnesota Transplant Conference. “Chronic Allograft Nephropathy: New Insight into an old problem”. 1998

    36. Maryland Academy of Family Practice Annual Meeting. “Prevention of Hypertensive Cardiovascular Disease”. 1998

    37. International Congress of the Transplant Society, Montreal, Canada. “New insight into the treatment of chronic allograft nephropathy”. 1998

    38. European Society of Cardiology, Vienna, Austria. “How to prevent diabetic nephropathy”. 1998

    39. Visiting Professor, Massachusetts General Hospital. Two conferences: Transplant Clinical Conference and Research Conference. Both on Chronic deterioration of renal disease in transplant patients. 1998

    40. New England Deaconess Hospital Surgical Grand Rounds: Chronic Allograft Nephropathy. 1998

    41. Medical Grand Rounds, Ohio State University. Hypertensive Renal Disease in African Americans. 1998

    42. Medical Grand Rounds. National Naval Medical Center. “Salt Sensitivity and Progressive Renal Injury”. 1999

    43. Visiting Professor. Shanghai University, China - Chronic Allograft Nephropathy: New Strategies. 1999

    44. Plenary Symposium. Annual Meeting American Society of Hypertension. “Is it the drug or blood pressure reduction which is important for renal protection. 1999

    45. Visiting Professor. Dalhousie University, Nova Scotia. “New strategies in chronic allograft nephropathy”. 1999

    46. Visiting Professor Western University, London, England. “New strategies in chronic allograft nephropathy”. 1999

    47. University of Alabama, Birmingham Research Conference. “Hypertension and the kidney”. 1999

    48. Satellite Symposium American Society of Nephropathy Annual Meeting. “New strategies in diabetic nephropathy, Miami, FL 1999.

    49. Endocrine Grand Rounds. George Washington University Hospital. Washington, D.C., “Diabetic Nephropathy”. 1999

    50. Plenary Speaker. Southeast Asia Endocrine Society. Bangkok, Thailand. Update in diabetic nephropathy. 1999

    51. Hahnemann University Medical Grand Rounds. “Hypertension and the kidney” 1999

    Stopped listing in 1999 due to space constraints.


  • 1   2   3   4   5   6   7


    The database is protected by copyright ©dentisty.org 2016
    send message

        Main page